Skip to main content
SpringerLink
Log in

Type V-Familial Hyperprebeta-Lipoproteinemia and Hyperchylomicronemia

  • Chapter
Fettstoffwechsel

Part of the book series: Handbuch der inneren Medizin ((INNEREN 7,volume 7 / 4))

  • 76 Accesses

Abstract

The Type V pattern on lipoprotein electrophoresis is characterized by a combination of chylomicrons at the electrophoretic origin, and increased staining density of the prebetalipoproteins. This combination of chylomicrons (exogenous triglycerides) and very low density lipoproteins (endogenous triglycerides) is often described in descriptive phrases which are synonymous with Type V: familial endogenous and exogenous hyperglyceridemia, familial mixed hyperlipemia.

Supported, in part, by N.I.H. Grant 1 RO1 HD 04851, and by the General Clinical Research Center Grant RR-00068-10. A portion of this work was done during Dr. Glueck’s tenure as an Established Investigator of the American Heart Association, 1971–1976.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 64.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 84.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  • Bagdade, J.D.: Diabetic lipemia complicating acute pancreatitis. Lancet 1969c I, 1041–1043.

    Article  Google Scholar 

  • Bagdade, J.D., Porte, D., Jr., Bierman, E.: Diabetic Lipemia (A Form of Acquired Fat-Induced Lipemia). New Engl. J. Med. 276, 427–433 (1967a).

    Article  PubMed  CAS  Google Scholar 

  • Bagdade, J.D., Porte, D., Jr., Bierman, E.L.: Hypertriglyceridemia: A metabolic consequence of chronic renal failure. New Engl. J. Med. 279, 181–185 (1968 b).

    Article  PubMed  CAS  Google Scholar 

  • Bank, S., Marks, I.N.: Hyperlipaemic pancreatitis and the pill. Postgrad. Med. J. 46, 576–578 (1970).

    Article  PubMed  CAS  Google Scholar 

  • Banks, P.A.: Acute pancreatitis. Gastroenterology 61, 382–397 (1971).

    PubMed  CAS  Google Scholar 

  • Bierman, E.L., Gordis, E., Hamlin, J.I., III: Heterogeneity of fat particles in plasma during alimentary lipemia. J. clin. Invest. 41, 2254 (1962).

    Article  PubMed  CAS  Google Scholar 

  • Cameron, J.L., Crisler, C., Margolis, S., DeMeester, T.R., Zuidema, G.D.: Acute pancreatitis with hyperlipemia. Surgery 70, 53–61 (1971).

    PubMed  CAS  Google Scholar 

  • Fallat, R.W., Glueck, C.J.: Familial and acquired type V hyperlipoproteinemia. Atherosclerosis 23, 41–62 (1976).

    Article  PubMed  CAS  Google Scholar 

  • Fredrickson, D.S., Levy, R.I.: Familial hyperlipoproteinemia. In: The Metabolic Basis of Inherited Disease (Eds. Stanbury, J.B., Wyngaarden, J.B., Fredrickson, D.S.), 3rd Ed. New York: McGraw-Hill 1972a.

    Google Scholar 

  • Fredrickson, D.S., Levy, R.I., Jones, E., Bonnell, M., Ernst, N.: The dietary management of hyperlipoproteinemia. A Handbook for Physicians, p. 83. Washington: U.S. Dept. of Health, Education, and Welfare, Public Health Service 1970d.

    Google Scholar 

  • Fredrickson, D.S., Levy, R.I., Kwiterovich, P.O., Jover, A.: The typing of hyperlipoproteinemia: a progress report. Drugs Affecting Lipid Metabolism (Eds. Holmes, W.L., Carlson, L.A., Paoletti, R.). New York: Plenum Press 1968b.

    Google Scholar 

  • Fredrickson, D.S., Levy, R.I., Lees, R.S.: Fat transport in lipoproteins: an integrated approach to mechanisms and disorders. New Engl. J. Med. 276, 32–44, (1967c).

    Google Scholar 

  • Fredrickson, D.S., Levy, R.I., Lees, R.S.: Fat transport in lipoproteins: an integrated approach to mechanisms and disorders. New Engl. J. Med. 276, 94–103, (1967c).

    Article  PubMed  CAS  Google Scholar 

  • Fredrickson, D.S., Levy, R.I., Lees, R.S.: Fat transport in lipoproteins: an integrated approach to mechanisms and disorders. New Engl. J. Med. 276, 215–226, (1967c).

    Article  PubMed  CAS  Google Scholar 

  • Fredrickson, D.S., Levy, R.I., Lees, R.S.: Fat transport in lipoproteins: an integrated approach to mechanisms and disorders. New Engl. J. Med. 276, 273–281 (1967c).

    Article  PubMed  CAS  Google Scholar 

  • Glueck, C.J.: Effects of oxandrolone on plasma triglycerides and post-heparin lipolytic activity in patients with types III, IV and V familial hyperlipoproteinemia. Metabolism 20, 691–712 (1971e).

    Article  PubMed  CAS  Google Scholar 

  • Glueck, C.J., Brown, W.V., Levy, R.I., Greten, H., Fredrickson, D.S.: Amelioration of hypertriglyceridemia by progestational drugs in familial type V hyperlipoproteinemia. Lancet 1969c I, 1290–1291.

    Article  Google Scholar 

  • Glueck, C.J., Kaplan, A.P., Levy, R.I., Greten, H., Gralnick, H.R., Fredrickson, D.S.: A new mechanism of exogenous hyperglyceridemia. Ann. intern. Med. 71, 1051–1062 (1969a).

    PubMed  CAS  Google Scholar 

  • Glueck, C.J., Levy, R.I., Fredrickson, D.S.: Immunoreactive insulin, glucose tolerance, and carbohydrate inducibility in types II, III, IV, and V hyperlipoproteinemia. Diabetes 18, 739–747, (1969d).

    PubMed  CAS  Google Scholar 

  • Glueck, C.J., Levy, R.I., Frederickson, D.S.: Norethindrone acetate, post-heparin lipolytic activity and plasma triglycerides in patients with familial types I, III, IV, and V hyperlipoproteinemia. Ann. intern. Med. 75, 345–352 (1971 g).

    PubMed  CAS  Google Scholar 

  • Glueck, C.J., Scheel, D., Fishback, J., Steiner, P.: Estrogen induced pancreatitis in patients with previously covert familial type V hyperlipoproteinemia. Metabolism 21, 657–665 (1972b).

    Article  PubMed  CAS  Google Scholar 

  • Glueck, C.J., Scheel, D., Fishback, J., Steiner, P.: Progestagens, anabolic-androgenic compounds, estrogens: Effects on triglycerides and post-heparin lipolytic enzymes. Lipids 7, 110–113 (1972f).

    Article  PubMed  CAS  Google Scholar 

  • Hazzard, W.R., Spiger, M.J., Bierman, E.L.: Studies on the mechanism of hypertriglyceridemia induced by oral contraceptives. In: Metabolic Effects of Gonadal Hormones and Contraceptive Steroids (Eds. Salhanick, H.A., Kipnis, D.M., Vande Wiele, R.S.), p. 232. New York: Plenum Press 1969.

    Google Scholar 

  • Kudzma, D.J., Schonfeld, G.: Alcoholic hyperlipidemia: Induction by alcohol but not by carbohydrate. J. Lab. clin. Med. 77, 384–395 (1971).

    PubMed  CAS  Google Scholar 

  • Levy, R.I., Glueck, C.J.: Hypertriglyceridemia, diabetes mellitus and coronary vessel disease. Arch. intern. Med. 123, 220–228 (1969a).

    Article  PubMed  CAS  Google Scholar 

  • Levy, R.I., Fredrickson, D.S.: The current status of hypolipidemic drugs. Postgrad. Med. 47, 130–136 (1970b).

    PubMed  CAS  Google Scholar 

  • Loffler, A., Filippini, L., Pulver, W.: Exocrine pancreatic insufficiency with familial hyperlipoproteinemia. Schweiz, med. Wschr. 101, 634–637 (1971).

    CAS  Google Scholar 

  • Lossow, W.J., Lindgren, F.T., Weizel, A., Wood, P.D.: A study of a type V hyperlipoproteinemic patient. Clin. chimica Acta 36, 33–41 (1972).

    Article  CAS  Google Scholar 

  • Morris, J.H., West, D.A., Bolinger, R.E.: Effect of oral sulfonylurea on plasma triglycerides in diabetic. Diabetes 13, 87–89 (1964).

    PubMed  CAS  Google Scholar 

  • Nikkila, E.A.: Control of plasma and liver triglyceride kinetics by carbohydrate metabolism and insulin. Advanc. Lipid Res. 7, 63–134 (1969).

    CAS  Google Scholar 

  • Nixon, J.C., Martin, W.G., Kalab, M., Monahan, G.J.: Type V hyperlipoproteinemia. A study of a patient and family. Clin. Biochem. 2, 389 (1969).

    Article  CAS  Google Scholar 

  • Parker, F., Bagdade, J.D., Odland, G.F., Bierman, E.L.: Evidence for the chylomicron origin of lipids accumulating in diabetic eruptive xanthomas: A correlative lipid, biochemical, histochemical and electron microscopic study. J. clin. Invest. 49, 2187 (1970).

    Article  Google Scholar 

  • Reaven, G.M., Lerner, R.L., Stern, M.P., Farquhar, J.W.: Role of insulin in endogenous hypertriglyceridemia. J. clin. Invest. 46, 1756–1767 (1967).

    Article  PubMed  CAS  Google Scholar 

  • Salen, S., Kessler, J.I., Janowitz, H.D.: The development of pancreatic secretory insufficiency in a patient with recurrent pancreatitis and a type V hyperlipoproteinemia. J. Mount Sinai Hosp. 37, 103–107 (1970).

    CAS  Google Scholar 

  • Sandhofer, F.: Studies of a clinical case of fat-induced (exogenous) hypertriglyceridemia. Schweiz. med. Wschr. 98, 458–461 (1968).

    PubMed  Google Scholar 

  • Schreiber, M.M., Shapiro, S.I.: Secondary eruptive xanthoma. Arch. Derm. 100, 601–603 (1969).

    Article  PubMed  CAS  Google Scholar 

  • Schwartz, M.J., Mirsky, S., Schaefer, L.E.: The effect of phenformin hydrochloride on serum cholesterol and triglyceride levels of the stable adult onset diabetic. Metabolism 15, 808–822 (1966).

    Article  PubMed  CAS  Google Scholar 

  • Steiner, G.: Lipoprotein lipase in fat-induced hyperlipemia. New Engl. J. Med. 279, 70–74 (1968).

    Article  PubMed  CAS  Google Scholar 

  • Stern, M.P., Silvers, A., Reaven, G.M., Groebin, J. Von Der: Prevalence of plasma lipoprotein abnormalities in a free living population of the Central Valley, California. Circulation 45, 114–126 (1972).

    PubMed  Google Scholar 

  • Strum, W.B., Spiro, H.M.: Chronic pancreatitis. Ann. intern. Med. 74, 91–95 (1971).

    Google Scholar 

  • Vogelberg, K.H., Gries, F.A., Miss, H.D., Jahnke, K.: The hyperlipemia in chronic alcohol abuse. Dtsch. med. Wschr. 96, 13–21 (1971).

    Article  PubMed  CAS  Google Scholar 

  • Zieve, L.: Relationship between acute pancreatitis and hyperlipemia. Med. Clin. N. Amer. 52, 1493–1501 (1968).

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. C. J. Glueck
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Ford
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. Fallat
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Abteilung für Klinische Chemie der Universitätskliniken, Joseph-Stelzmann-Straße 9, D-5000, Köln 41, Deutschland

    G. Assmann

  2. Klinisches Institut für Herzinfarktforschung, Medizinische Universitätsklinik, Bergheimer Straße 58, D-6900, Heidelberg, Deutschland

    J. Augustin , H. Greten , G. Middelhoff  & G. Schlierf , ,  & 

  3. Section and Laboratory of Liver Diseases, Nutrition and Alcoholism, Veterans Administration Hospital, 130 West Kingsbridge Road, Bronx, N.Y., 10468, USA

    E. Baraona  & C. S. Lieber  & 

  4. Mt. Sinai School of Medicine(CUNY), New York, N.Y., USA

    E. Baraona  & C. S. Lieber  & 

  5. Institut für Hirnforschung der Universität, Belthlestraße 15, D-7400, Tübingen, Deutschland

    H. U. Benz  & K. Harzer  & 

  6. Internistische Germeinschaftspraxis, Dialyse-Institut, Werastraße 33, D-7990, Friedrichshafen, Deutschland

    W. Brech

  7. Division of Metabolic Disease, Department of Medicine, School of Medicine, University of California, La Jolla, California, 92037, USA

    W. V. Brown

  8. Departments of Pediatrics, Genetics and Cell Biology and The Dight Institute of Human Genetics, University of Minnesota, Box 231, Mayo Memorial Building, Minneapolis, Minnesota, 55455, USA

    R. J. Desnick

  9. Department of Internal Medicine, College of Medicine, Lipid Research Clinic, University of Cincinnati Medical Center, 234 Goodman Street, Cincinnati, Ohio, 45229, USA

    W. R. Fallat

  10. Lipid Research Center, University of Cincinnati, Cincinnati, Ohio, 45229, USA

    S. Ford  & Ch. J. Glueck  & 

  11. General Clinical Research Center, University of Cincinnati, Cincinnati, Ohio, 45229, USA

    S. Ford  & Ch. J. Glueck  & 

  12. National Institutes of Health, Bethesda, Maryland, 20014, USA

    D. Fredrickson

  13. Molecular Disease Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, 20014, USA

    P. Herbert  & R. I. Levy  & 

  14. Institut für Medizinische Biochemie der Universitä, Harrachgasse 21, A-8010, Graz, Öterreich

    G. M. Kostner

  15. Department of Pediatrics, University of Minnesota, Box 231, Mayo Memorial Building, Minneaplis, Minnesota, 55455, USA

    W. Krivit

  16. Medizinische Universitätsklinik, Bergheimer Straße 58, D-6900, Heidelberg, Deutschland

    M. Liersch , G. Schettler , E. Stange  & A. Weizel , ,  & 

  17. Courtauld Institute of Biochemistry, Middlesex Hospital Medical School, London W 1, England

    G. L. Mills

  18. Medical Research Council Lipid Metabolism Unit, Hammersmith Hospital, Ducane Road, London, W12 OHS, England

    N. B. Myant  & J. Slack  & 

  19. Departments of Pediatrics, University of Minnesota Medical School, Minneapolis, Minnesota, 55455, USA

    R. F. O’Dea

  20. Research Associate in the Pharmacology, Laboratory of Clinical Science, National Institute of Mental Health, Bethesda, Maryland, 20014, USA

    R. F. O’Dea

  21. Innere Abteilung, Knappschafts-Krankenhaus, Am Deimelsberg 34a, 4300, Essen-Steele, Deutschland

    J. Papenberg

  22. Neurologische Klinik und Poliklinik der Universität, v. Siebold-Straße 5, D-3400, Göttingen, Deutschland

    H. Pilz

  23. Schierghoferstraße 24a, D-8220, Traunstein/Obb, Deutschland

    H. M. Rauen

  24. Medizinische Universitätsklinik, Anich-Straße 35, A-6020, Innsbruck, Austria

    S. Sailer

  25. Abteilung für Experimentlle Zellforschung, Physiologisch-Chemisches Institute der Universität, Waldeyerstraße 15, D-4400, Münster/Westf, Deutschland

    H. Schriewer

  26. Klinisch-Chemisches Laboratorium, Medizinische Universitätsklinik, Bergheimer Straße 58, D-6900, Heidelberg, Deutschland

    D. Seidel  & H. Wieland  & 

  27. Department of Experimental Medicine and Cancer Research, Hebrew University Hadassah Medical School, Jerusalem, Israel

    O. Stein

  28. Lipid Research Laboratory, Department of Medicine B, Hadassah University Hospital, Jerusalem, Israel

    Y. Stein

  29. Division of Metabolic Disease, Department of Medicine, School of Medicine, University of California, San Diego, La Jolla, California, 92093, USA

    D. Steinberg

Rights and permissions

Reprints and permissions

Copyright information

© 1976 Springer-Verlag Berlin · Heidelberg

About this chapter

Cite this chapter

Glueck, C.J., Ford, S., Fallat, R. (1976). Type V-Familial Hyperprebeta-Lipoproteinemia and Hyperchylomicronemia. In: Assmann, G., et al. Fettstoffwechsel. Handbuch der inneren Medizin, vol 7 / 4. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-66302-4_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-66302-4_12

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-66303-1

  • Online ISBN: 978-3-642-66302-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation